CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC TO-I/A Deal Tender Offer Statement by Issuer
- 4 Open-market buy CEO and President bought 7,500 shares at an average $0.66 ($4,925)
- UPLOAD Other SEC-generated Letter
- 8-K Event Unregistered share sale · Shareholder rights changed · Other events
- SC TO-I Deal Tender Offer Statement by Issuer
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed
- 4 Open-market buy CEO and President bought 2,500 shares at $0.90 ($2,250)
- 4 Open-market buy CEO and President bought 2,500 shares at $0.92 ($2,300)
- 8-K Event Other events
- 4 Open-market buy Director bought 8,000 shares at $0.95 ($7,600)
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Conversion Director acquired 2,388,541 shares (conversion)
- SC 13D/A Stake Beneficial Ownership Report
Page 40 of 47 · 929 filings